CLINICAL_TRIALS ClinicalTrials.gov record update

Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06967961
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:32.048528+00:00
Published At: 2025-07-29T00:00:00+00:00
Record Updated At: 2025-07-29
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Urothelial Carcinoma", "Renal Cancer", "Prostate Adenocarcinoma", "Adenocarcinoma of Endometrium", "Cutaneous Melanoma", "Soft Tissue Sarcoma (STS)", "Nonseminomatous Germ Cell Tumor", "Seminomatous Germ Cell Tumor", "Upper Aerodigestive Tract Carcinoma", "Cervical Carcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-07-29"
protocolSection.identificationModule.nctId: "NCT06967961"
protocolSection.identificationModule.officialTitle: "Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.